A Multicenter Retrospective Analysis of Outcomes and Toxicities with Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas
暂无分享,去创建一个
P. Riedell | M. Perales | D. Porter | W. Hwang | M. Bishop | S. Schuster | O. Oluwole | V. Bachanova | R. Maziarz | L. Nastoupil | M. Pennisi | J. Mcguirk | Chase Walling